Suppr超能文献

海洋大环内酯类药物应对. 的抗微生物药物耐药性

Marine Macrolides to Tackle Antimicrobial Resistance of .

机构信息

Department of Pharmacy, Faculty of Pharmacy, Hasanuddin University, Makassar 90245, Indonesia.

Department of Pharmaceutical Science and Technology, Faculty of Pharmacy, Hasanuddin University, Makassar 90245, Indonesia.

出版信息

Mar Drugs. 2022 Nov 1;20(11):691. doi: 10.3390/md20110691.

Abstract

Tuberculosis has become a major health problem globally. This is worsened by the emergence of resistant strains of showing ability to evade the effectiveness of the current antimycobacterial therapies. Therefore, the efforts carried out to explore new entities from many sources, including marine, are critical. This review summarizes several marine-derived macrolides that show promising activity against . We also provide information regarding the biosynthetic processes of marine macrolides, including the challenges that are usually experienced in this process. As most of the studies reporting the antimycobacterial activities of the listed marine macrolides are based on in vitro studies, the future direction should consider expanding the trials to in vivo and clinical trials. In addition, in silico studies should also be explored for a quick screening on marine macrolides with potent activities against mycobacterial infection. To sum up, macrolides derived from marine organisms might become therapeutical options for tackling antimycobacterial resistance of .

摘要

结核病已成为全球主要的健康问题。耐药菌株的出现使情况恶化,这些菌株显示出逃避现有抗分枝杆菌疗法效果的能力。因此,从包括海洋在内的多种来源探索新实体的努力至关重要。这篇综述总结了几种具有抗结核活性的海洋衍生大环内酯类药物。我们还提供了有关海洋大环内酯类生物合成过程的信息,包括该过程中通常遇到的挑战。由于报告列出的海洋大环内酯类抗分枝杆菌活性的大多数研究都是基于体外研究,因此未来的方向应该考虑将试验扩展到体内和临床试验。此外,还应探索计算机模拟研究,以便快速筛选对分枝杆菌感染具有有效活性的海洋大环内酯类药物。总之,来源于海洋生物的大环内酯类药物可能成为解决抗分枝杆菌耐药性的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e821/9697125/0a3c8bec3cbc/marinedrugs-20-00691-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验